Edwards Lifesciences Corporation
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | $822.3M | $2.62B | $930.1M |
| FY2017 | $438.4M | $2.96B | $818.3M |
| FY2018 | $593.8M | $3.14B | $714.1M |
| FY2019 | $594.4M | $4.15B | $1.18B |
| FY2020 | $595.0M | $4.57B | $1.18B |